Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Hua Han Bio-Pharma and China National Biotec Announce JV

publication date: Apr 23, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
A subsidiary of Hua Han Bio-Pharmaceutical Holdings, Guizhou Factorr Bio-Technology Co., signed a framework agreement to set up a JV with National Vaccine & Serum Institute. NVSI is a Beijing-based company that is part of the China National Biotec Group. Guizhou will fund the JV with between 30 and 50 million RMB of capital ($5-8 million), while NVSI will contribute rights to three biopharma products. More details....

Stock Symbol: (HK: 00587)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners